Author(s):
K. Naga Durga, P. Bhuvaneswari, B. Hemalatha, K. Padmalatha
Email(s):
Email ID Not Available
DOI:
10.52711/2231-5713.2022.00027 
Address:
K. Naga Durga1, P. Bhuvaneswari1, B. Hemalatha1*, K. Padmalatha2
1Department of Pharmaceutics, Vijaya Institute of Pharmaceutical Sciences for Women, Vijayawada.
2Department of Pharmacology, Vijaya Institute of Pharmaceutical Sciences for Women, Vijayawada.
*Corresponding Author
Published In:
Volume - 12,
Issue - 2,
Year - 2022
ABSTRACT:
Nowadays about 74% of drugs are taken orally and are found not to be as effective as required. To improve such characters transdermal drug delivery system was emerged. Drug delivery through the skin to attain a systemic effect of a drug is commonly known as transdermal drug delivery and differs from traditional topical drug delivery. Transdermal drug delivery systems (TDDS) are dosage forms involves drug transport to viable epidermal and or dermal tissues of the skin for local therapeutic effect while a very major fraction of drug is transported into the systemic blood circulation. The adhesive of the transdermal drug delivery system is critical to the safety, efficacy and quality of the product. Topical administration of therapeutic agents offers many advantages over conventional oral and invasive methods of drug delivery. Several important advantages of transdermal drug delivery are limitation of hepatic first pass metabolism, enhancement of therapeutic efficiency and maintenance of steady plasma level of the drug. This review article provides an overview of advantages and disadvantages, factors affecting transdermal drug delivery, components and types of transdermal drug delivery, methods of preparation and methods of evaluation.
Cite this article:
K. Naga Durga, P. Bhuvaneswari, B. Hemalatha, K. Padmalatha. A Review on Transdermal Drug Delivery System. Asian Journal of Pharmacy and Technology. 2022; 12(2):159-6. doi: 10.52711/2231-5713.2022.00027
Cite(Electronic):
K. Naga Durga, P. Bhuvaneswari, B. Hemalatha, K. Padmalatha. A Review on Transdermal Drug Delivery System. Asian Journal of Pharmacy and Technology. 2022; 12(2):159-6. doi: 10.52711/2231-5713.2022.00027 Available on: https://ajptonline.com/AbstractView.aspx?PID=2022-12-2-13
REFERENCES:
1. Ashvini S. Kadam, Mukesh P. Ratnaparkhi, Shilpa P. Chaudhary. Transdermal drug delivery: An overview. International Journal of Research and Development in Pharmacy and Life Sciences 2014; 3(4): 1042 – 1053.
2. J. Ashok Kumar, Nikhila Pullakandam, S. Lakshmana Prabu, V. Gopal. Transdermal drug delivery system: An overview. International Journal of Pharmaceutical Sciences Review and Research 2010; 3(2): 49 – 54.
3. Latheeshjlal.L, P. Phanitejaswini, Y. Soujanya, U. Swapna, V. Sarika, G. Moulika. Transdermal drug delivery systems: An overview. International Journal of Pharm Tech Research 2011; 3(4): 2140 – 2148.
4. Richa Sachan, Meenakshi Bajpai. Transdermal drug delivery system: A review. International Journal of Research and Development in Pharmacy and Life Sciences 2013; 3(1): 748 – 765.
5. Dipen Patel, Sunita A. Chaudhary, Bhavesh Parmar, Nikunj Bhura. Transdermal drug delivery system: A review. The Pharma Journal 2012; 1(4): 65 – 75.
6. H. Michael Wolff. Future of Transdermal drug delivery systems. American Pharmaceutical Review 2014; 3(2): 1 – 6.
7. Shalu Rani, Kamal Saroha, Navneet Syan, Pooja Mathur. Transdermal patches a successful tool in Transdermal drug delivery system: An overview. Pelagia Research Library 2011; 2(5): 17 – 29.
8. Mark R. Prausnitz and Robert Langer. Transdermal drug delivery. Nat Biotechnol. 2008; 26 (11): 1261 – 1268.
9. Ahlam Zaid Alkilani, Maeliosa T. C. Mc Crudden and Ryan F. Donnelly. Transdermal drug delivery: Innovative Pharmaceutical Developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015; 7: 438 – 470.
10. Anna M. Wokovich. Suneela Prodduturi, William H. Doub. Ajaz S. Hussain, Lucinda F. Buhse. Transdermal drug delivery system adhesion as a critical safety, efficacy and quality attribute. European Journal of Pharmaceutics and Biopharmaceutics 2006; 64 (1): 1 - 8.
11. Berner B and John V.A. Pharmacokinetic characterization of Transdermal delivery systems. Jour. Clinical pharmacokinetics 1994; 26 (2): 121 - 34.
12. Jalwal P, Jangra A, Dhaiya L, Sangwan Y, Saroha R. A review on transdermal patches. Pharm Res. J. 2010; 3: 139 - 149.
13. Bhowmik D, Chiranjib, Chandira M, Jayakar B, Sampath KP. Recent advances in transdermal drug delivery system. Int. J Pharm Tech Res. 2010; 2(1):68 - 77.
14. Kumar A, Pullankandam N, Prabhu SL, Gopal V. Transdermal drug delivery system: an overview. Int. J Pharm Sci. Review Res. 2010; 3(2):49 - 54.
15. Divya A, Rao MK, Gnanprakash K, Sowjanya A, Vidyasagar N, Gobinath M. A review on current scenario of transdermal drug delivery system. Int. J Res. Pharm Sci. 2012; 3(4):494 - 502.
16. Rani S, Saroha K, Syan N, Mathur P. Transdermal patches a successful tool in transdermal drug delivery system. Plegia Res. Lib. 2011; 2(5): 17 - 29.
17. Patel D, Chaudhary SA, Parmar B, Bhura N. Transdermal drug delivery system: a review. The Pharm Innovation. 2012; 1(4): 66-75.
18. Ramteke KH, Dhole SN, Patil SV. Transdermal drug delivery system: a review. J Advanced Sci. Res. 2012;3(1):22-35.
19. Yadav V. Transdermal drug delivery system: review. Int. J Pharm Sci. Res. 2012; 3(2): 376-382.
20. Sharma RK, Keleb E, Mosa EB, Aljahwi AAZ. Transdermal drug delivery system- design and evaluation. Int. J Advances Pharm Sci. 2010; 1: 201 - 211.
21. Sandhu P, Bilandi A, Kataria S, Middha A. Transdermal drug delivery system (patches), applications in present scenario. Int. J Res. Pharm Chem. 2011; 1(4): 1139 - 1151.
22. Singh MC, Naik AS, Sawant SD. Transdermal drug delivery system with major emphasis on transdermal patches: a review. J Pharm Res. 2010; 3(10): 2537 - 2543.
23. Yadav B, Sharma B, Saroha K. Transdermal patches: a discrete dosage form. Int. J Current Pharm Res. 2011; 3(3): 98 - 108.
24. Gupta IK, Chokshi MM. Transdermal drug delivery system: an overview. Asian J Pharm Sci. Clinical Res. 2011; 1(1): 25 - 43.
25. Jatav VS, Saggu JS, Jat RK, Sharma AK, Singh RP. Recent advances in development of transdermal patches. Pharmacophore Int. Res. J. 2011; 2(6): 287 - 297.
26. Arunachalam A, Karthikeyan M, Kumar DV, Pratap M, Sethuraman S, Kumar SA. Transdermal drug delivery system: review. Current Pharm Res. 2010; 1(1): 70 - 81.
27. Wokovich AM, Prodduturi S, Doub WH, Hussain AS, Buhse LF. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eup. J Pharm BioPharm. 2006; 64: 1 - 8.
28. Dhiman S, Thakur GS, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int. J Pharmacy Pharm Sci. 2011; 3(5): 26 - 34.
29. Lende LK, Grampurohit ND, Gaikwad DD, Gadhave MV, Jadhav SL. Transdermal patches: a review. Int. J Pharm Res. Dev. 2011; 4(3): 96 - 103.
30. Sakalle P, Dwivedi S, Dwivedi A. Design, evaluation, parameters and marketed products of transdermal patches: a review. J Pharm Res. 2010; 3(2): 235 - 240.
31. Sachan B, Bajpai M. Transdermal drug delivery system: A review. Int. J Res. Dev. Pharm and life Sci. 2013; 3(1): 748 - 765.
32. Bathe R, Kapoor R. Transdermal drug delivery system: formulation, development and evaluation - An overview. J Biomedical and Advance Res 2015; 6(01): 1 - 10.
33. Mali AD, Bathe R, Patil M. An updated review on transdermal drug delivery systems. Int. J advances Sci. Res. 2015; 1(06): 244 - 254.
34. Gaikwad AK. Transdermal drug delivery system: Formulation aspects and evaluation. Comprehensive J Pharm Sci. 2013; 1(1): 1 - 10.
35. Shingade GM, Aamer Q, Sabale PM, Grampurohit ND, Gadhave MV, Jadhav SL, Gaikwad D. Review on: Recent Trends on Transdermal Drug Delivery System. J Drug Delivery Therapeutics 2012; 2(1): 66 - 75.